Hims & Hers Health, Inc. (HIMS)

NYSE: HIMS · IEX Real-Time Price · USD
7.09
+0.27 (3.96%)
At close: Aug 11, 2022 4:00 PM
7.10
+0.01 (0.14%)
Pre-market: Aug 12, 2022 8:02 AM EDT
3.96%
Market Cap 1.46B
Revenue (ttm) 373.75M
Net Income (ttm) -83.03M
Shares Out 206.06M
EPS (ttm) -0.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,531,928
Open 6.93
Previous Close 6.82
Day's Range 6.84 - 7.22
52-Week Range 2.72 - 9.35
Beta 0.49
Analysts Buy
Price Target 6.44 (-9.2%)
Earnings Date Aug 8, 2022

About HIMS

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, a... [Read more...]

Industry Household & Personal Products
Founded 2017
Employees 398
Stock Exchange NYSE
Ticker Symbol HIMS
Full Company Profile

Financial Performance

In 2021, HIMS's revenue was $271.88 million, an increase of 82.77% compared to the previous year's $148.76 million. Losses were -$107.66 million, 494.3% more than in 2020.

Financial Statements

Analyst Forecast

According to 14 analysts, the average rating for HIMS stock is "Buy." The 12-month stock price forecast is 6.44, which is a decrease of -9.17% from the latest price.

Price Target
$6.44
(-9.17% downside)
Analyst Consensus: Buy
Stock Forecasts

News

Hims & Hers CEO: We deliver health care at prices that are ‘cheaper than insurance'

#Hims&HersCEO Hims & Hers Founder & CEO Andrew Dudum joins Yahoo Finance Live to discuss health care costs and birth control access in a post-Roe world.

Hims & Hers Health, Inc. (HIMS) Reports Q2 Loss, Tops Revenue Estimates

Hims & Hers Health, Inc. (HIMS) delivered earnings and revenue surprises of 0% and 11.50%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Hims & Hers Health, Inc. Reports Second Quarter 2022 Financial Results and Raises Full Year 2022 Outlook

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to cons...

This Stock Is Up 30% in 1 Month, With More Upside Ahead

What stock soars 30% in this market? Hims & Hers.

Hims & Hers Health, Inc. (HIMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Hims & Hers Health, Inc. (HIMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Hims & Hers Health, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 8, 2022

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to ...

This Former SPAC Looks Recession-Proof

Hims & Hers has the growth and the cash to last.

7 Penny Stocks That Actually Have Analyst Buy Ratings

Many penny stocks (stocks trading for less than $5 per share) have little analyst coverage, but these seven have sell-side "buy" ratings. The post 7 Penny Stocks That Actually Have Analyst Buy Ratings a...

Other symbols: CANGEVONOKOPADPAYORIG

Hims & Hers Announces 2022 Pride Tour Partnership with Drag Superstars Violet Chachki, Gottmik, and LGBTQ Youth Suppo...

SAN FRANCISCO--(BUSINESS WIRE)--Internationally recognized drag superstars Violet Chachki and Gottmik have come together for their first tour to celebrate Pride season.

Hers Doubles Down On Commitment To Women's Wellness With Launch of 6 New Hers Wellness Essentials Supplements

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers is revealing today, Hers Wellness Essentials, six new supplements formulated specifically for women.

This Growth Stock Expects Sales to Rise by at Least 51% This Year

Investors could be overlooking an attractive investment opportunity with Hims & Hers right now.

Hims & Hers Health, Inc. (HIMS) Reports Q1 Loss, Tops Revenue Estimates

Hims & Hers Health, Inc. (HIMS) delivered earnings and revenue surprises of 11.11% and 12.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Hims & Hers Health, Inc. Reports First Quarter 2022 Financial Results and Raises Full Year 2022 Revenue Outlook

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals and provides acce...

Hims & Hers Health: 3 Keys to Earnings

Big things could be happening at this telehealth company.

Will Hims & Hers Health, Inc. (HIMS) Report Negative Earnings Next Week? What You Should Know

Hims & Hers Health, Inc. (HIMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 Things About Hims & Hers Health That Smart Investors Know

Hims & Hers is a young company with a bright future ahead.

Hims & Hers Health, Inc. to Announce First Quarter 2022 Financial Results and Host Conference Call on May 9, 2022

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to ...

This Telehealth Stock's Rapid Product Launches Should Benefit Investors

Hims and Hers is rapidly expanding its brand across multiple healthcare categories.

Hims & Hers and Carbon Health Partner to Expand Care Options for California Customers

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to ...

Hims & Hers Doubles Skincare Product Offerings With a Suite of New Products for Increased Personalized Care to Help A...

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers unveils the expansion of their skincare collections, offering new skincare products to support a wide range of skincare concerns.

1 Telehealth Company That Could Turn $1,000 into $10,000

In fearful markets, bold investors can find ample opportunity.

7 Cheap Stocks to Buy If You Only Have $100 to Spend

You can find many good stocks to buy for under $10. And here are seven cheap stocks that are good buys even if you only have $100 to spend.

Other symbols: APPHCOTYFUBOPCTSOFI

Hims & Hers to Expand Curated Educational Programs and Offerings Through Exclusive Partnership With Goodpath

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers to Expand Curated Educational Programs and Offerings Through Exclusive Partnership With Goodpath

Hims & Hers Appoints Uber Vet Amee Parekh as SVP of Human Resources

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Appoints Uber Vet Amee Parekh as SVP of Human Resources .

Top 3 Cheap Healthcare Stocks You Shouldn't Ignore.

Some popular names in the healthcare sector have been down even by about 50% from their highs recently. But there are lots of opportunities in this sector.

Other symbols: NVCRTDOC